Can Fever-Tree's feverish growth go on?
Sales are booming for Fever-Tree, the premium drinks firm. But can it maintain its spectacular rate of growth?
Sales are booming for Fever-Tree, the premium drinks firm. But can it maintain its spectacular rate of growth?
A bullish update from Fever-Tree (LSE: FEVR), the maker of posh drinks mixers, went down well with pun-loving financial journalists, who described the firm's progress as "sparkling" and "fizzing". Investors were pleased too, with the share price "bubbling up to new highs", says Holly Black in the Daily Mail. The stock gained 10% on Monday and has now risen by more than 500% since it listed two years ago.
The latest update builds on strong interim results published in July, which showed sales growth of 69% in the first half of 2016, amid "particularly notable performance" in retail sales. Fever-Tree's upmarket tonics and lemonades were originally sold in restaurants, cocktail bars and gastro-pubs, but sales have been bolstered by bringing its products into the mass market, with a "march into low-price supermarkets", says Joanna Bourke in the Evening Standard. With Fever-Tree's products now on the shelves in Asda, it is now present in "every major supermarket" in the UK.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Still, the stock now trades on a forecast price-to-earnings (p/e) ratio of 52, says Andrea Felsted on Bloomberg.com. "To keep up that effervescence, Fever-Tree needs to carry on delivering the earnings upgrades. But there are a few risks to that frankly feverish rate of expansion." One is the fickleness of fashion. Fever-Tree has built its success on the back of the boom in artisanal gin so favoured by metropolitan hipsters. But "if millennials move away from premium spirits", says Felsted, "that would put its punchy pace in peril". A second risk is Brexit. The UK accounts for 45% of sales, making it vulnerable to any slowdown in the economy that might be prompted by leaving the EU. Third, while it has stolen a march on the competition, it may not have the premium market to itself forever. "Big consumer companies struggling to find new sources of growth might well turn their attention to premium mixers."
Quite, says Ashley Armstrong in The Daily Telegraph. There's been "a gulf between the upmarket tonic company and its soft drinks rivals, which have been struggling in the deflationary environment", but the firm now faces competition from the likes of Fentimans, 1724, and Bottle Green. Schweppes is also coming up with premium versions of its mixers. Still, while there's no guarantee Fever-Tree can hold on to its market leadership, many shareholders aren't betting on that, says Felsted. Instead, they can see that Fever-Tree is "just the sort of upstart, nimble and youth-approved company that has the entrenched behemoths salivating". At £1.2bn, the firm would be "a mere sip" for Diageo or Coca-Cola. The prospect of bids from the big boys should prevent its share price from "going too flat" anytime soon.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Ben studied modern languages at London University's Queen Mary College. After dabbling unhappily in local government finance for a while, he went to work for The Scotsman newspaper in Edinburgh. The launch of the paper's website, scotsman.com, in the early years of the dotcom craze, saw Ben move online to manage the Business and Motors channels before becoming deputy editor with responsibility for all aspects of online production for The Scotsman, Scotland on Sunday and the Edinburgh Evening News websites, along with the papers' Edinburgh Festivals website.
Ben joined MoneyWeek as website editor in 2008, just as the Great Financial Crisis was brewing. He has written extensively for the website and magazine, with a particular emphasis on alternative finance and fintech, including blockchain and bitcoin.
As an early adopter of bitcoin, Ben bought when the price was under $200, but went on to spend it all on foolish fripperies.
-
Cash hoarders take total UK savings to £2 trillion – why aren’t we investing?
Investment-shy Brits are hoarding huge amounts of cash in their savings accounts. We look at the case for saving versus investing.
By Katie Williams Published
-
The MoneyWeek Christmas Charity Appeal: who are we supporting and how to donate
This year MoneyWeek is supporting YoungMinds, tackling mental health for children and young people. Here’s why we are partnering with YoungMinds and how you can help.
By Kalpana Fitzpatrick Published